Samuel Waxman, M.D., is a distinguished oncologist/hematologist who has dedicated his career to developing minimally toxic cancer therapies. His work focuses on reprogramming cancer cells to behave like normal cells, a less toxic approach that has yielded significant breakthroughs. A key achievement includes his collaborative role in finding a cure for acute promyelocytic leukemia (APL), … Continued

Wylie G. Tené is a seasoned communications and public relations executive with over 20 years of experience across healthcare, non-profit, and entertainment sectors. Prior to the launch of the Samuel Waxman Institute for Aging & Cancer, Wylie served as Director of Marketing and Communications at the Samuel Waxman Cancer Research Foundation, where he led brand … Continued

Amaia Lujambio joined The Mark Foundation in September 2025. She came to The Mark Foundation from the Icahn School of Medicine at Mount Sinai, where she worked as a tenured Associate Professor specializing in liver cancer research through the development of precision mouse models. Previously, Amaia conducted postdoctoral research at Memorial Sloan Kettering Cancer Center … Continued

Meredith Henning joined the Mark Foundation in June 2025 as Grants & Data Operations Coordinator.

Raymond N. DuBois (Ray), MD, PhD, joined The Mark Foundation for Cancer Research as Executive Chairman of the Board in February 2022, leading the board of directors as well as taking on an executive leadership role at the Foundation. He is also Director of MUSC Hollings Cancer Center, an NCI-designated cancer center, and a Distinguished … Continued

Ryan Schoenfeld, PhD, is Chief Executive Officer of The Mark Foundation for Cancer Research, a philanthropic organization dedicated to transforming the prevention, diagnosis, and treatment of cancer around the world. An experienced scientific leader, Ryan oversees the Foundation’s scientific programs, investments, and operations. Ryan joined The Mark Foundation in 2018, was named Chief Scientific Officer … Continued

Rebecca joined The Mark Foundation as Scientific Program Director in November 2017. She came to The Mark Foundation from D. E. Shaw Research, a firm engaged in scientific research and technological development in the field of computational biochemistry.

Alex Knaster is Chairman and CEO of Pamplona Capital Management, an investment management firm he founded in 2004, with private equity, hedge fund and fund of funds operations. Alex has more than 25 years of experience in the investment banking industry.